Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Haike Biotechnology is a Chinese in vitro diagnostics and medical device company focused on quantitative allergy testing. The company develops, manufactures, and sells allergy diagnostic instruments and matching reagent kits, with an emphasis on high-precision allergen-specific IgE testing. It has been described as HYCOR Biomedical's Chinese manufacturing partner and distributor for allergy products in China. A key commercial product is the ALLEOS 2000 system, a China-registered allergy testing platform positioned to provide a broad reagent menu including allergen mixes, purified extracts, and molecular components. The company appears to operate as a private, active healthcare company based in Changsha, Hunan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Haike Biotechnology.